| pubmed-article:20014137 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20014137 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:20014137 | lifeskim:mentions | umls-concept:C0000726 | lld:lifeskim |
| pubmed-article:20014137 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:20014137 | lifeskim:mentions | umls-concept:C0041618 | lld:lifeskim |
| pubmed-article:20014137 | lifeskim:mentions | umls-concept:C0850292 | lld:lifeskim |
| pubmed-article:20014137 | lifeskim:mentions | umls-concept:C1553497 | lld:lifeskim |
| pubmed-article:20014137 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20014137 | pubmed:dateCreated | 2010-3-15 | lld:pubmed |
| pubmed-article:20014137 | pubmed:abstractText | Contrast-enhanced CT is regarded as the gold standard for monitoring radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC). Recently, 3-dimensional volume data from CT have been used to create cross-sectional multiplanar reconstruction images. Using this technique, we can reconstruct 2-dimensional CT images identical in orientation to ultrasound (US) images, which we call virtual sonographic (VUS) images. The present prospective randomized control trial compared the number of CT scans needed to assess the efficacy of RFA of HCC using VUS-contrast-enhanced ultrasonography (CEUS) versus CT. | lld:pubmed |
| pubmed-article:20014137 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20014137 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20014137 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20014137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20014137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20014137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20014137 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20014137 | pubmed:issn | 1097-0096 | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:AbeMasanoriM | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:OnjiMorikazuM | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:MatsuuraBunzo... | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:HiasaYoichiY | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:HirookaMasash... | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:KisakaYoshiya... | lld:pubmed |
| pubmed-article:20014137 | pubmed:author | pubmed-author:KoizumiYoheiY | lld:pubmed |
| pubmed-article:20014137 | pubmed:copyrightInfo | Copyright 2009 Wiley Periodicals, Inc. | lld:pubmed |
| pubmed-article:20014137 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20014137 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:20014137 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20014137 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20014137 | pubmed:pagination | 138-44 | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:meshHeading | pubmed-meshheading:20014137... | lld:pubmed |
| pubmed-article:20014137 | pubmed:articleTitle | Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:20014137 | pubmed:affiliation | Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon, Ehime 791-0295, Japan. | lld:pubmed |
| pubmed-article:20014137 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20014137 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
